Home
Our Expertise
Our Team
Careers
Contact Us

Also in News

EWCP led a multi-million dollar Series A funding round joined by US-based investment firms GRI Fund, ASAP Ventures and prominent Angel Investors in cell therapy company, Seraxis Pte Ltd.more...
Scottish early stage Biopharmaceuticals company Lamellar Biomedical
raised $5.3 million in
December 2012.more...
EWCP signs agreement with European Family office to jointly Manage & Fund a cancer drug delivery company.more...
EWCP provides advice to strategic investor to acquire stake in ITL Limited.more...
 

News Room



East West Capital Partners have completed an investment into the UK medical device company Braidlock Ltd

Braidlock has pioneered the use of braided tubes as a means of securing external lines from sites of surgical intervention. The idea was developed at the Great Ormond Street Hospital, the world-famous children's hospital in London. EWCP contributed 25% of the investment and have two board seats including the Chairman role. Initially the product will be manufactured in the UK with higher volumes being manufactured in Southeast Asia. The company plans to establish a sales base in the UK through the NHS and expand into Europe. There is already considerable demand for Braidlock's products in SE Asia and Korea. Braidlock's are a cheap and secure way of external line fixation which can save the payer industry considerable costs compared to other commercially-available devices as well as making life easier for practitioners, both nurses and physicians.

East West Capital Partners (EWCP). All Rights Reserved. Sitemap